Pmv Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.81-$1.84 |
Market Cap | $77.8M |
Shares Short | 808,829 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.56 |
News
See moreYahoo Finance • 15 days ago
Get insights into the top gainers and losers of Wednesday's pre-market session.
Yahoo Finance • 15 days ago
PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
Yahoo Finance • 2 months ago
PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights
Yahoo Finance • 3 months ago
Ticktin Robert, general counsel, sells PMV Pharma shares for $24,651
About
CEO | Dr. David H. Mack Ph.D. |
Address | 400 Alexander Park Drive, Princeton, NJ, United States, 08540 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 47 |
